Bristol-Myers Squibb | BMY - Actif À Court Terme





Actif À Court Terme Changement Date
AbbVie USD 37.48B 3.81B 2026-09
Abbott USD 23.5B 1.02B 2026-09
ALKERMES USD 1.58B 57.83M 2026-09
Amgen USD 34.36B 598M 2026-09
AstraZeneca USD 31.45B 3.48B 2026-09
Biogen USD 7.58B 278.7M 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Coherus Biosciences USD 133.79M 72.25M 2026-06
Drreddys Laboratories INR 297.58B 4.4B 2026-09
Eli Lilly USD 65.26B 591M 2026-09
Gilead Sciences USD 16.55B 4.02B 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
J&J USD 56.35B 3.42B 2026-09
Medtronic USD 24.39B 397M 2026-06
Merck USD 38.94B 2.26B 2026-09
Novartis USD 28.75B 1.4B 2026-09
Novo Nordisk DKK 208.7B 31.38B 2026-06
Perrigo USD 2.4B 49.7M 2026-09
Pfizer USD 45.01B 3.65B 2026-09
Phibro Animal Health USD 945.17M 9.67M 2026-09
Prestige Brands USD 492.13M 4.69M 2026-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 33.21B 1.68B 2026-09
Sanofi EUR 31.52B 1.36B 2026-06
United Therapeutics USD 2.88B 603.5M 2026-09
Zoetis USD 6.29B 63M 2026-09